Patents by Inventor Simona Mendelovitz

Simona Mendelovitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11781119
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: April 19, 2022
    Date of Patent: October 10, 2023
    Assignee: Horizon Therapeutics USA, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20230034252
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: April 19, 2022
    Publication date: February 2, 2023
    Inventors: Jacob HARTMAN, Simona MENDELOVITZ
  • Patent number: 11345899
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: May 31, 2022
    Assignee: HORIZON THERAPEUTICS USA, INC.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20210079362
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: June 24, 2020
    Publication date: March 18, 2021
    Inventors: Jacob HARTMAN, Simona MENDELOVITZ
  • Patent number: 10731139
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: August 4, 2020
    Assignee: Horizon Pharma Rheumatology LLC
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20190316097
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: November 28, 2018
    Publication date: October 17, 2019
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Patent number: 10160958
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: December 25, 2018
    Assignee: Horizon Pharma Rheumatology LLC
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Patent number: 9926538
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: March 27, 2018
    Assignee: Horizon Pharma Rheumatology LLC
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Patent number: 9926537
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: March 27, 2018
    Assignee: Horizon Pharma Rheumatology LLC
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20170321193
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: July 13, 2017
    Publication date: November 9, 2017
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20170313995
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: July 13, 2017
    Publication date: November 2, 2017
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20170313994
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: July 13, 2017
    Publication date: November 2, 2017
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20170313993
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: July 13, 2017
    Publication date: November 2, 2017
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20170298326
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: April 18, 2017
    Publication date: October 19, 2017
    Applicant: HORIZON PHARMA RHEUMATOLOGY LLC
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Patent number: 9670467
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: June 6, 2017
    Assignee: HORIZON PHARMA RHEUMATOLOGY LLC
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20150197732
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: March 27, 2015
    Publication date: July 16, 2015
    Applicant: CREALTA PHARMACEUTICALS LLC
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Patent number: 9017980
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: August 21, 2013
    Date of Patent: April 28, 2015
    Assignee: Crealta Pharmaceuticals LLC
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Publication number: 20130330803
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Application
    Filed: August 21, 2013
    Publication date: December 12, 2013
    Applicant: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Patent number: 8541205
    Abstract: Genetically modified proteins with uricolytic activity are described. Proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidase are described.
    Type: Grant
    Filed: May 1, 2012
    Date of Patent: September 24, 2013
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz
  • Patent number: 8465735
    Abstract: The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: June 18, 2013
    Assignee: Savient Pharmaceuticals, Inc.
    Inventors: Jacob Hartman, Simona Mendelovitz